Connecting to LinkedIn...

W1siziisijiwmtuvmdqvmtuvmdgvntqvmzgvnzi1l01ptlrbu0hfqkxpr19vtljftkrfukvex0lnqudfx3jlc2l6zwrfyw5kx3jlbmrlcmvklmpwzyjdlfsiccisinrodw1iiiwimtkymhgxmjuwiyjdxq

Blog

Mylan to Buy Abbott’s Generic Drug Business Outside U.S. for $5.3 Billion

14/07/2014 by

W1siziisijiwmtqvmtavmjgvmtuvmzmvmtyvnti3l2zpbguixsxbinailcj0ahvtyiisijywmhg0mdbcdtawm2uixv0

Abbott Laboratories said on Monday that it had agreed to sell its established generic drug business outside the United States to the generic drug maker Mylan in an all-stock deal that valued at about $5.3 billion.

Under the deal, Abbott will take a 21 percent stake worth about $5.3 billion in a new company that combines Mylan’s existing business with Abbott’s developed markets pharmaceuticals operations in Europe, Japan, Canada, Australia and New Zealand.

The transaction will allow Mylan to engage in a so-called inversion: the Pennsylvania company would reincorporate in the Netherlands to lower its corporate taxes and to free up cash held in overseas entities.

Mylan, whose headquarters are in Pittsburgh, unsuccessfully pursued the Swedish drug maker Meda this year in hopes of engaging in an inversion.

“We have been actively looking at a wide range of opportunities, and the acquisition of this business is absolutely the right next strategic transaction for Mylan as it builds on our strong momentum, expands and further diversifies our business in our largest markets outside of the U.S.,” Robert J. Coury, the Mylan executive chairman, said in a statement.

This article has been extracted from http://dealbook.nytimes.com, please click on this link to read the article in full http://dealbook.nytimes.com/2014/07/14/mylan-to-buy-generics-drugs-business-outside-u-s-from-abbott-for-5-3-billion/

Montash is a multi-award winning, global IT recruitment firm. Specialising in permanent and contract positions across mid-senior appointments which cover a wide range of industry sectors and IT functions, including:

ERP, BI & Data, Information Security, IT Architecture & Strategy, Scientific Technologies, Demand IT and Business Engagement, Digital and E-commerce, Infrastructure and Service Delivery, Project and Programme Delivery.

With offices based in London, Montash has completed assignments in over 30 countries and has appointed technical professionals from board level to senior and mid-management in permanent and contract roles.

comments powered by Disqus

Social Stream

Latest News

W1siziisijiwmtyvmtivmdivmtavmdcvntcvotkwl2j1c2luzxnzigludgvsbglnzw5jzs5qcgcixsxbinailcj0ahvtyiisijm4mhgxmdajil1d

Annual growth rate for BI market set at 8.4%

2016-12-02 10:00:00 +0000

A new report has suggested that the compound average growth rate (CAGR) for the business intelligence (BI) market between 2016 and 2021 is likely to be around 8.4 per cent. The latest publication, named Global Business Intelligence Market by Mobile BI, Cloud BI, and Other Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015-2021, said that 2015 saw the global BI sector valued at $16.33 billion. By 2021, this is expected t...

W1siziisijiwmtyvmtevmzavmtavmjavntuvndgzl09jbcbyawcgc2vhlmpwzyjdlfsiccisinrodw1iiiwimzgwedewmcmixv0

Crisis in oil and gas industry nears turning ...

2016-11-30 10:00:00 +0000

A new report has suggested that the current crisis being experienced by the gas and oil industry is nearing a turning point. As part of the 25th Oil and Gas Survey, it was found that although two-thirds of firms had cut employment levels in 2015, the speed at which these cuts are occurring has slowed. In addition, other methods of saving have been utilised to drive operational costs down. Amongst the firms questioned, it was found that 67 per cent of bu...